Jan 09, 2023 / 05:00PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Thanks, everyone. We'll get started here. I'm Robbie Marcus, the med tech analyst at JPMorgan. I'm very happy to have Medtronic as our next company here. I'm going to call up Geoff Martha, Chairman and CEO, and then we'll do a little Q&A after. Geoff? All right. Thank you.
Geoffrey Straub Martha - Medtronic plc - Chairman of the Board & CEO
All right. Thanks, Robbie. Okay. Thanks for the introduction, Robbie, and thanks to all of you for joining the Medtronic presentation this morning and what looks like to be a packed house and despite the rain or at least the threat of rain, it wasn't nearly as bad as we were told. It's great to be back in person here in San Francisco.
And before I get started, I do want to remind you of some disclosures, including that I'll be making some forward-looking statements today that and may reference some non-GAAP financial measures. And I encourage you to read these disclosures. These are also available on our Investor Relations website as
Medtronic PLC at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot